“Preclinical Potency, Affinity, and Pharmacokinetics of APG990, a Half-Life Extended Antibody Against OX40L” (2025) SKIN The Journal of Cutaneous Medicine, 9(2), p. s551. doi:10.25251/skin.10.supp.551.